Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval
Liquidia has received tentative approval from the US Food and Drug Administration (FDA) for YUTREPIA (treprostinil) inhalation powder.
Liquidia has received tentative approval from the US Food and Drug Administration (FDA) for YUTREPIA (treprostinil) inhalation powder.
What's Your Reaction?
